Skip to main content
. Author manuscript; available in PMC: 2020 Sep 28.
Published in final edited form as: Gynecol Oncol. 2018 Mar 28;149(2):301–309. doi: 10.1016/j.ygyno.2018.02.012

Table 3.

Independent prognostic factors (multivariate analysis).

Characteristic Disease-free survival Cause-specific survival
HR (95% CI) P-value HR (95% CI) P-value
Age (years)
 <60 1 1
 ≥60 2.41 (1.53–3.80) <0.001 3.18 (1.34–7.57) 0.009
BMI (kg/m2)
 <30 1
 ≥30 0.22 (0.06–0.77) 0.018
Grade
 1–2 1 1
 3 2.39 (1.38–4.15) 0.002 5.58 (2.45–12.7) <0.001
Myometrial invasion
 Inner half 1 1
 Outer half 1.79 (1.07–2.99) 0.025 2.55 (1.05–6.20) 0.038
Cervical stromal invasion
 Absent 1
 Present 2.70 (1.48–4.95) 0.001
LVSI
 Absent 1 1
 Present 2.09 (1.25–3.50) 0.005 3.43 (1.41–8.32) 0.006
Peritoneal cytology
 Negative cytology 1 1
 Abnormal cytologya 3.07 (1.81–5.23) <0.001 3.42 (1.39–8.42) 0.008
Postop radiotherapy
 No 1
 Yes 1.88 (1.07–3.30) 0.028
Postop chemotherapy
 No 1 1
 Yes 0.52 (0.29–0.93) 0.026 0.30 (0.13–0.72) 0.007

Cox proportional hazard regression models for P-values. All the covariates with P < 0.05 on univariate analysis were entered in the initial model, and only the significant covariates with P < 0.05 in the final model are shown (conditional backward). Significant P-values are emboldened. Abbreviations: BMI, body mass index; LVSI, lympho-vascular space invasion; HR, hazard ratio; and CI, confidence interval.

a

Malignant or atypical cells on peritoneal cytology results.